PACB
Pacific Biosciences of California, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.35
+3.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -12.63x
- Price / sales
- 2.63x
- Price / cash flow
- -2.58x
Enterprise value
- Enterprise value
- $888.9M
- EV / sales
- 5.58x
- EV / EBITDA
- -8.15x
- EV / EBIT
- -5.47x
- Market cap
- $419.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026